Mark Douglas Smith - 15 Jun 2026 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Reporting relationship: Director
Issuer ticker: JAZZ
Reported as of: 15 Jun 2026
Net transaction value: -$266,746
SEC form: 4
Accepted by SEC: 17 Jun 2026, 16:45:12 UTC
Prior SEC filing: 21 May 2026
Next SEC filing: 26 Jun 2026
Source filing: View source filing
Reporting owner signature: By: /s/Paz Dizon, as attorney in fact For: Mark D. Smith

Key filing fact

Mark Douglas Smith filed Form 4 for Jazz Pharmaceuticals plc (JAZZ) on 17 Jun 2026.

Key facts

This page summarizes Mark Douglas Smith's Form 4 filing for Jazz Pharmaceuticals plc (JAZZ).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 17 Jun 2026, 16:45.

Change

Previous filing in this sequence was filed on 21 May 2026.
Current net transaction value: -$266,746.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001756253 Primary reporting owner

Smith Mark Douglas

Relationship: Director
Address: 5TH FL, WATERLOO EXCHANGE, WATERLOO RD, DUBLIN 4, IRELAND
Signature: By: /s/Paz Dizon, as attorney in fact For: Mark D. Smith
Signature date: 17 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

JAZZ transaction

Ordinary Shares

Sale

Transaction value: $266,746
Shares: -1,157
Change %: -11%
Price: $230.55
Shares after: 9,680
Date: 15 Jun 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 1 footnote

Footnote F1

This transaction was made pursuant to a plan adopted by the reporting person on March 9, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person.